Among 7,308 people with both atrial fibrillation and Alzheimer's, those on newer NOAC blood thinners lost cognitive ground more slowly than patients on warfarin or no anticoagulant at all. NOAC users also faced lower risks of death, stroke and fractures, though the observational study can't prove the drugs caused the improvement.

— via ScienceDaily